Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Julphar
Johnson and Johnson
Healthtrust
Teva
McKinsey
US Army
Baxter
Harvard Business School
Colorcon

Generated: January 18, 2018

DrugPatentWatch Database Preview

Kythera Biopharms Company Profile

« Back to Dashboard

What is the competitive landscape for KYTHERA BIOPHARMS, and what generic alternatives to KYTHERA BIOPHARMS drugs are available?

KYTHERA BIOPHARMS has one approved drug.

There are thirteen US patents protecting KYTHERA BIOPHARMS drugs.

There are eighty-three patent family members on KYTHERA BIOPHARMS drugs in twenty-nine countries and one supplementary protection certificate in one country.

Summary for Kythera Biopharms
International Patents:83
US Patents:13
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Kythera Biopharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Kythera Biopharms KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Kythera Biopharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,362,285 Preparation of bile acids and intermediates thereof ➤ Subscribe
9,186,364 Formulations of deoxycholic acid and salts thereof ➤ Subscribe
9,150,607 Preparation of bile acids and intermediates thereof ➤ Subscribe
9,737,549 Formulations of deoxycholic acid and salts thereof ➤ Subscribe
9,724,356 Formulations of deoxycholic acid and salts thereof ➤ Subscribe
8,367,852 Preparation of bile acids and intermediates thereof ➤ Subscribe
7,994,351 Preparation of bile acids and intermediates thereof ➤ Subscribe
7,902,387 Preparation of bile acids and intermediates thereof ➤ Subscribe
9,050,349 Synthetic bile acid compositions and methods ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Kythera Biopharms Drugs

Supplementary Protection Certificates for Kythera Biopharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017006 Lithuania ➤ Subscribe PRODUCT NAME: DEZOKSICHOLIO RUGSTIES NATRIO DRUSKA; REGISTRATION NO/DATE: LT/1/16/3960/001 20160909
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Medtronic
Johnson and Johnson
Express Scripts
Queensland Health
AstraZeneca
UBS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot